Disease/Condition
1,536 Clinical Trials
10+ Countries
Type 2 Diabetes Mellitus Clinical Trials Database - Free Access to 1,536 Studies
Access comprehensive clinical trial information for Type 2 Diabetes Mellitus through Pure Global AI's free database. This collection includes 1,536 clinical trials across multiple phases including N/A, Phase 3, Phase 1. Currently, 98 trials are actively recruiting participants.
Research for Type 2 Diabetes Mellitus is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include AstraZeneca and Merck Sharp & Dohme LLC. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
N/A
598Phase 3
293Phase 1
197Phase 4
195Phase 2
140By Status
Completed
1,120Unknown
126Recruiting
98Not yet recruit...
80Terminated
63Top Countries
United States of America255
China149
Japan145
South Korea78
Canada40
Top Sponsors
AstraZeneca108
Merck Sharp & Dohm...100
Sanofi76
Eli Lilly and Comp...41
Takeda32
Recent Trials
Latest clinical trials for Type 2 Diabetes Mellitus
SLCTR_2015_014
Not Applicable
The impact of patient education on controlling Type 2 diabetes
Prof. P. A BallSri Lanka
SLCTR_2017_010
Phase 2/3
Effect of Ceylon cinnamon in lowering blood glucose for type 2 diabetes mellitus
University of ColomboSri Lanka
SLCTR_2014_036
Phase 3
Completed
A Study of the Safety and Efficacy of MK-0431A in participants aged 10-17 years with Type 2 Diabetes Mellitus.
Merck Sharp and Dohme CorpArgentina, Bulgaria, Canada, Chile, Colombia, Costa Rica, Dominican Republic, Germany, Guatemala, Is
SLCTR_2023_019
Not Applicable
Impact of nurse-based WhatsApp Counselling on diabetes medication adherence, severity of adverse drug reactions and hypoglycemic / hyperglycemic complications, among type 2 diabetes patients at a tertiary care hospital in Sri Lanka: a randomized controlled study
Colombo North Teaching Hospita...Sri Lanka
2014-004993-40
A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents
Merck & Co., Inc.
2014-003964-18
Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With Type 2 diabetes mellitus (T2DM)
Bristol-Myers Squibb Company
PHRR210913-003895
Phase 4
Ongoing
Type II Diabetes Mellitus Patient Preference Study
AstraZeneca Pharmaceuticals (P...Philippines
2020-003731-22
A Study to Assess the Pharmacokinetics and Ability for Pediatric Patients with Type 2 Diabetes to Swallow MK-0431A XR Tablets
Merck Sharp & Dohme Corp., a s...
SLCTR_2016_028
Not Applicable
Recruiting
Effectiveness of an intervention package to improve compliance to pills among patients with type 2 diabetes mellitus: A randomized controlled trial
Medical Research Institute, Sr...Sri Lanka
SLCTR_2012_010
Not Applicable
Completed
Effects of Zinc supplementation on diabetes prevention
National Science FoundationSri Lanka
SLCTR_2015_022
Phase 4
Sitagliptin compared to glimepiride on vascular risk factors among patients with type 2 diabetes mellitus
University Grants Commission, ...Sri Lanka
SLCTR_2018_004
Not Applicable
Recruiting
Study to assess the role of rifaximin in glycaemic control of poorly controlled diabetics.
Faculty of Medicine, Universit...Sri Lanka
SLCTR_2014_037
Phase 3
Completed
A Study of the Safety and Efficacy of MK-0431A XR, a Fixed-Dose Combination Tablet of Sitagliptin and Extended-Release Metformin in Pediatric Participants aged 10-17 years With Type 2 Diabetes Mellitus
Merck Sharp and Dohme CorpAustralia, Brazil, Bulgaria, Canada, Chile, Colombia, Costa Rica, Czech Republic, Denmark, Georgia,
NCT06422039
Phase 1
Not yet recr...
Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects
Shandong Suncadia Medicine Co....China
NCT06411275
Phase 2
Completed
A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise
HighTide Biopharma Pty LtdChina
NCT06385704
Not yet recr...
Research on Changes in Intestinal Barrier Function and Gut Microbiome in Patients With Type 2 Diabetes After Duodenal Mucosal Resurfacing (DMR)
Wang Siqi
NCT06362265
Phase 1
Not yet recr...
A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus
Eli Lilly and CompanyUnited States of America
NCT06353347
Phase 3
Recruiting
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
HighTide Biopharma Pty LtdChina
NCT06339086
Phase 3
Not yet recr...
Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes
Chengdu Brilliant Pharmaceutic...
NCT06293664
Recruiting
Protocol for Alpha MSH Infusion Study in Patients With Type 2 Diabetes
Dasman Diabetes InstituteKuwait
About Type 2 Diabetes Mellitus Research
Pure Global AI provides free access to 1,536 clinical trials studying Type 2 Diabetes Mellitus, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include AstraZeneca, Merck Sharp & Dohme LLC, Sanofi, among others.
Quick Facts
Total Trials1,536
Countries10+
Sponsors10+
Recruiting98